A1707 — Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

A1707 — Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs · Informed CitizenryThe bill amends the insurance law by adding a new section, § 111-A, regarding notification of prescription drug price increases by manufacturers. The requirements apply to any manufacturer of a pr…Open in Informed Citizenry